We are currently developing new technologies for concentration and analysis of various cell types including bacteria, yeast, mammalian cells, and various forms of eDNA from a broad range of sample matricies.
Our patented VLFS technology enables automated, programmable flow switching and mixing for miniaturized bioassays without the need for mechanical microvalves or other integrated moving parts. This technology is employed in commercial platforms for automated immunoassays, spheroid assays, and organoid assays.